LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

DexCom Inc

Fermé

SecteurSoins de santé

86.7 1.1

Résumé

Variation du prix de l'action

24h

Actuel

Min

85.71

Max

87.34

Chiffres clés

By Trading Economics

Revenu

-46M

105M

Ventes

-78M

1B

P/E

Moyenne du Secteur

64.293

51.198

BPA

0.32

Marge bénéficiaire

10.174

Employés

10,200

EBITDA

-109M

134M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+15.05% upside

Dividendes

By Dow Jones

Prochains Résultats

24 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.1B

34B

Ouverture précédente

85.6

Clôture précédente

86.7

Sentiment de l'Actualité

By Acuity

50%

50%

166 / 380 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

DexCom Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 oct. 2024, 09:10 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 juil. 2024, 20:16 UTC

Résultats

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 juil. 2024, 09:13 UTC

Actualités
Actions en Tendance

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 juil. 2024, 08:56 UTC

Actualités

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 juin 2024, 16:01 UTC

Résultats

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Comparaison

Variation de prix

DexCom Inc prévision

Objectif de Prix

By TipRanks

15.05% hausse

Prévisions sur 12 Mois

Moyen 98.64 USD  15.05%

Haut 110 USD

Bas 85 USD

Basé sur 18 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

18 ratings

17

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

71.66 / N/ASupport & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Neutral Evidence

Sentiment

By Acuity

166 / 380Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.